SKYE
SKYE
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
13
$3.87M
Total Volume
$3.87M
18 transactions
Net Activity
$3.87M
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
5Am Partners Vii, LLC
10%
$1.25M total
Schwab Andrew J.
Dir, 10%
$1.25M total
Arsenault Kaitlyn
CFO
$432K total
Grayson Paul A.
Dir
$432K total
Dhillon Punit
CEO
$414K total
Quick Actions
SKYE has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at SKYE (SKYE) engaged in a total of 18 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 13 were sales. The total volume of insider trading reached $3.87M.
The net insider activity for SKYE shows a net selling bias of $3.87M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by 5Am Partners Vii, LLC (10%), who traded 231.4K shares valued at $801K on Aug 21, 2025.
SKYE - Skye Bioscience Inc Stock Price and Quote
Skye Bioscience director Andrew Schwab sells $239,555 in common stock
Skye Bioscience CFO Resigns, CEO Assumes Financial Role
symbol__ Stock Quote Price and Forecast
Skye Bioscience: SKYE Stock Price Quote & News
Skye’s shares crash down to earth on Phase II obesity loss
FAQs About SKYE Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for SKYE.